Regeneron Pharmaceuticals (REGN)
Long-Term Investments
$9.83B
Quarterly · Period ending: · USD

REGN Long-Term Investments
Latest reported$9.83Bperiod ending
Latest reported$9.83Bperiod ending
REGN Quarterly Long-Term Investments ($0.00 → $9.83B)
Quarterly long-term investments
High-resolution chart · PNG
REGN long-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Investments (USD) |
|---|---|
| 9,828,300,000 | |
| 9,786,000,000 | |
| 10,260,600,000 | |
| 10,285,700,000 | |
| 10,058,200,000 | |
| 9,276,300,000 | |
| 8,900,100,000 | |
| 8,490,900,000 | |
| 7,722,400,000 | |
| 6,978,800,000 | |
| 5,396,500,000 | |
| 5,778,500,000 | |
| 6,327,200,000 | |
| 6,066,600,000 | |
| 6,591,800,000 | |
| 5,968,600,000 | |
| 6,415,900,000 | |
| 7,084,000,000 | |
| 6,838,000,000 | |
| 5,631,300,000 | |
| 3,900,300,000 | |
| 3,543,700,000 | |
| 3,135,600,000 | |
| 2,875,100,000 | |
| 2,587,600,000 | |
| 3,236,400,000 | |
| 3,256,800,000 | |
| 3,112,600,000 | |
| 2,884,600,000 | |
| 2,339,800,000 | |
| 1,755,000,000 | |
| 1,873,569,000 | |
| 2,044,703,000 | |
| 1,821,985,000 | |
| 1,486,494,000 | |
| 1,327,303,000 | |
| 1,064,677,000 | |
| 967,695,000 | |
| 864,260,000 | |
| 777,906,000 | |
| 589,852,000 | |
| 555,210,000 | |
| 632,162,000 | |
| 681,326,000 | |
| 589,595,000 | |
| 483,305,000 | |
| 460,154,000 | |
| 453,443,000 | |
| 550,818,000 | |
| 534,689,000 | |
| 389,891,000 | |
| 329,863,000 | |
| 173,328,000 | |
| 346,607,000 | |
| 271,230,000 | |
| 312,600,000 | |
| 288,321,000 | |
| 254,738,000 | |
| 275,887,000 | |
| 258,073,000 | |
| 251,256,000 | |
| 373,621,000 | |
| 370,053,000 | |
| 37,956,000 | |
| 70,465,000 | |
| 108,278,000 | |
| 47,080,000 | |
| 57,200,000 | |
| 72,845,000 | |
| 78,460,000 | |
| 51,061,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |